This update serves to correct that Pharmacopeia reported a sharp decrease in first-quarter revenues. An earlier version incorrectly reported in the first paragraph that there was a sharp increase in revenue. The article also should have mentioned that Pharmacopeia said in December last year it would change its name to Accelrys.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.